Tyler Engel is a principal and consulting actuary with the New York office of Milliman. He joined the firm in 2012.
Tyler provides a variety of skills, intelligence, and market strategy with a specialty in prescription drugs to a broad range of clients, including health plans, hospital systems, pharmaceutical companies, medical device manufacturers, healthcare industry trade organizations, disease and medical management vendors, and other healthcare providers.
For over a decade, he has helped these healthcare stakeholders address many new and arising challenges in the following areas:
Tyler is the editor and co-author of several publicly available white papers and peer review journal publications focused on health cost outcomes research and public policy.
Professional Designations
Education
Publications
